Particularly, it was revealed that Galectin 3 expressed by MSCs in the TME of acute myeloid leukemia (AML) activates MYC expression and contributes to the cell adhesion between MSC and AML tumor, thereby promoting the survival of cancer cells [98]. The gene discussed is MYC; the disease is acute myeloid leukemia.